ProCE Banner Activity

ExpressPoints
Addressing Clinical Challenges in T-Cell Lymphomas Through Biomarker-Driven Therapy

Slideset Download
Download this short summary slideset of key takeaway points from a CCO live symposium on biomarker-driven therapies for T-cell lymphomas.

Released: December 28, 2021

Expiration: December 27, 2022

No longer available for credit.

Share

Faculty

Francine Foss

Francine Foss, MD

Professor of Medical Oncology
Yale Cancer Center
Yale University School of Medicine
New Haven, Connecticut

Steven M. Horwitz

Steven M. Horwitz, MD

Assistant Attending Physician, Lymphoma Service
Department of Medicine
Memorial Sloan-Kettering Cancer Center
New York, New York

Barbara Pro

Barbara Pro, MD

Professor of Medical Oncology
Chief of Lymphoma Section
Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation
Kimmel Cancer Center
Thomas Jefferson University
Philadelphia, Pennsylvania

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Daiichi Sankyo, Inc.

Kyowa Kirin Inc

Seagen Inc.

Takeda Oncology

Faculty Disclosure

Primary Author

Francine Foss, MD

Professor of Medical Oncology
Yale Cancer Center
Yale University School of Medicine
New Haven, Connecticut

Steven M. Horwitz, MD

Assistant Attending Physician, Lymphoma Service
Department of Medicine
Memorial Sloan-Kettering Cancer Center
New York, New York

Barbara Pro, MD

Professor of Medical Oncology
Chief of Lymphoma Section
Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation
Kimmel Cancer Center
Thomas Jefferson University
Philadelphia, Pennsylvania

Additional Information

Program Medium

This program has been made available online.